113 related articles for article (PubMed ID: 16394175)
1. Effect of epidermal growth factor and prostaglandin on the expression of aromatase (CYP19) in human adrenocortical carcinoma cell line NCI-H295R cells.
Watanabe M; Noda M; Nakajin S
J Endocrinol; 2006 Jan; 188(1):59-68. PubMed ID: 16394175
[TBL] [Abstract][Full Text] [Related]
2. Aromatase expression in a human osteoblastic cell line increases in response to prostaglandin E(2) in a dexamethasone-dependent fashion.
Watanabe M; Noda M; Nakajin S
Steroids; 2007 Sep; 72(9-10):686-92. PubMed ID: 17614108
[TBL] [Abstract][Full Text] [Related]
3. Forskolin up-regulates aromatase (CYP19) activity and gene transcripts in the human adrenocortical carcinoma cell line H295R.
Watanabe M; Nakajin S
J Endocrinol; 2004 Jan; 180(1):125-33. PubMed ID: 14709151
[TBL] [Abstract][Full Text] [Related]
4. EP2 and EP4 receptors regulate aromatase expression in human adipocytes and breast cancer cells. Evidence of a BRCA1 and p300 exchange.
Subbaramaiah K; Hudis C; Chang SH; Hla T; Dannenberg AJ
J Biol Chem; 2008 Feb; 283(6):3433-3444. PubMed ID: 18083712
[TBL] [Abstract][Full Text] [Related]
5. Identification in human airways smooth muscle cells of the prostanoid receptor and signalling pathway through which PGE2 inhibits the release of GM-CSF.
Clarke DL; Belvisi MG; Catley MC; Yacoub MH; Newton R; Giembycz MA
Br J Pharmacol; 2004 Apr; 141(7):1141-50. PubMed ID: 15023863
[TBL] [Abstract][Full Text] [Related]
6. Prostaglandin (PG) FP and EP1 receptors mediate PGF2alpha and PGE2 regulation of interleukin-1beta expression in Leydig cell progenitors.
Walch L; Clavarino E; Morris PL
Endocrinology; 2003 Apr; 144(4):1284-91. PubMed ID: 12639911
[TBL] [Abstract][Full Text] [Related]
7. Proteinase-activated receptor-2 stimulates prostaglandin production in keratinocytes: analysis of prostaglandin receptors on human melanocytes and effects of PGE2 and PGF2alpha on melanocyte dendricity.
Scott G; Leopardi S; Printup S; Malhi N; Seiberg M; Lapoint R
J Invest Dermatol; 2004 May; 122(5):1214-24. PubMed ID: 15140225
[TBL] [Abstract][Full Text] [Related]
8. Prostaglandin E2-induced modification of tetrodotoxin-resistant Na+ currents involves activation of both EP2 and EP4 receptors in neonatal rat nodose ganglion neurones.
Matsumoto S; Ikeda M; Yoshida S; Tanimoto T; Takeda M; Nasu M
Br J Pharmacol; 2005 Jun; 145(4):503-13. PubMed ID: 15821755
[TBL] [Abstract][Full Text] [Related]
9. Prostaglandin E2 regulates aromatase activity and expression in human adipose stromal cells via two distinct receptor subtypes.
Richards JA; Brueggemeier RW
J Clin Endocrinol Metab; 2003 Jun; 88(6):2810-6. PubMed ID: 12788892
[TBL] [Abstract][Full Text] [Related]
10. Effects of Neonicotinoids on Promoter-Specific Expression and Activity of Aromatase (CYP19) in Human Adrenocortical Carcinoma (H295R) and Primary Umbilical Vein Endothelial (HUVEC) Cells.
Caron-Beaudoin É; Denison MS; Sanderson JT
Toxicol Sci; 2016 Jan; 149(1):134-44. PubMed ID: 26464060
[TBL] [Abstract][Full Text] [Related]
11. E series of prostaglandin receptor 2-mediated activation of extracellular signal-regulated kinase/activator protein-1 signaling is required for the mitogenic action of prostaglandin E2 in esophageal squamous-cell carcinoma.
Yu L; Wu WK; Li ZJ; Wong HP; Tai EK; Li HT; Wu YC; Cho CH
J Pharmacol Exp Ther; 2008 Oct; 327(1):258-67. PubMed ID: 18583546
[TBL] [Abstract][Full Text] [Related]
12. The prostaglandin transporter regulates adipogenesis and aromatase transcription.
Subbaramaiah K; Hudis CA; Dannenberg AJ
Cancer Prev Res (Phila); 2011 Feb; 4(2):194-206. PubMed ID: 21212407
[TBL] [Abstract][Full Text] [Related]
13. Prostaglandin E2 receptor EP1 transactivates EGFR/MET receptor tyrosine kinases and enhances invasiveness in human hepatocellular carcinoma cells.
Han C; Michalopoulos GK; Wu T
J Cell Physiol; 2006 Apr; 207(1):261-70. PubMed ID: 16331686
[TBL] [Abstract][Full Text] [Related]
14. 2-Chloro-s-triazine herbicides induce aromatase (CYP19) activity in H295R human adrenocortical carcinoma cells: a novel mechanism for estrogenicity?
Sanderson JT; Seinen W; Giesy JP; van den Berg M
Toxicol Sci; 2000 Mar; 54(1):121-7. PubMed ID: 10746939
[TBL] [Abstract][Full Text] [Related]
15. Signaling pathways regulating aromatase and cyclooxygenases in normal and malignant breast cells.
Richards JA; Petrel TA; Brueggemeier RW
J Steroid Biochem Mol Biol; 2002 Feb; 80(2):203-12. PubMed ID: 11897504
[TBL] [Abstract][Full Text] [Related]
16. Human granulosa-lutein cells express functional EP1 and EP2 prostaglandin receptors.
Harris TE; Squires PE; Michael AE; Bernal AL; Abayasekara DR
Biochem Biophys Res Commun; 2001 Aug; 285(5):1089-94. PubMed ID: 11478765
[TBL] [Abstract][Full Text] [Related]
17. Prostaglandin E2 down-regulation of cytochrome P-450 2B1 expression induced by phenobarbital is through EP2 receptor in rat hepatocytes.
Li CC; Shen HL; Lii CK; Liu KL; Yang JJ; Chen HW
Biochem Biophys Res Commun; 2005 Feb; 327(2):424-30. PubMed ID: 15629132
[TBL] [Abstract][Full Text] [Related]
18. Pioglitazone, a PPARγ agonist, suppresses CYP19 transcription: evidence for involvement of 15-hydroxyprostaglandin dehydrogenase and BRCA1.
Subbaramaiah K; Howe LR; Zhou XK; Yang P; Hudis CA; Kopelovich L; Dannenberg AJ
Cancer Prev Res (Phila); 2012 Oct; 5(10):1183-94. PubMed ID: 22787115
[TBL] [Abstract][Full Text] [Related]
19. Overexpression of aromatase P450 in leiomyoma tissue is driven primarily through promoter I.4 of the aromatase P450 gene (CYP19).
Shozu M; Sumitani H; Segawa T; Yang HJ; Murakami K; Kasai T; Inoue M
J Clin Endocrinol Metab; 2002 Jun; 87(6):2540-8. PubMed ID: 12050211
[TBL] [Abstract][Full Text] [Related]
20. Prostaglandin regulation of gastric slow waves and peristalsis.
Forrest AS; Hennig GW; Jokela-Willis S; Park CD; Sanders KM
Am J Physiol Gastrointest Liver Physiol; 2009 Jun; 296(6):G1180-90. PubMed ID: 19359421
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]